Regulating donor configuration to develop AIE-active type I photosensitizers for lipid droplet imaging and high-performance photodynamic therapy under hypoxia

AIE-active type I photosensitizers based on DHP were developed by regulating the donor configuration, in which SMP-CNPY with one methyl modification showed high-performance photodynamic therapy under hypoxia and lipid droplet targeting ability.